Demographics, demographics, demographics. That’s always a key factor when it comes to investing, and that’s especially true when it comes to investing in healthcare stocks. An aging global population, combined with a growing middle-class market and advances in medical technology makes this sector a sound long-term investment.
Investing in Healthcare Pros
The healthcare sector offers a wide range of investment choices. These include companies focusing on:
- Biotechnology
- Health insurers
- Healthcare technology
- Hospitals
- Life science tools
- Medical equipment and services
- Pharmaceuticals
As defensive stocks, this sector usually provides stable earnings not correlating to the stock market’s overall performance. Keep in mind that various industries in this sector react to market conditions based on how the particular industry is affected. For instance, COVID-19 boosted the stocks of companies developing testing and vaccines. The cancellation of elective surgeries during that period put a dent in the stock of many medical device manufacturers and for-profit hospitals.
Investing in Healthcare Cons
What’s the downside to investing in healthcare stocks? Overall, these stocks are subject to U.S. policy changes. Healthcare stocks are vulnerable to regulatory risks. When it comes to pharmaceutical stocks, an FDA recall or poor clinical trial results can affect share price severely.
There’s also the fact that the pandemic is still with us. While healthcare stocks have mostly recovered from the battering this novel event imposed, challenges still exist.
Top Healthcare Stocks
Stocks to consider when investing in healthcare include:
No. 4 Johnson & Johnson (NYSE: JNJ)
New Brunswick, New Jersey-based Johnson & Johnson calls itself “the world’s largest and most broadly-based healthcare company.” Founded in 1886, J&J products in its consumer health division include household names such as Band-Aid®, Benadryl, Motrin, Tylenol, and Zyrtec. That’s literally just naming a few. Its many subsidiaries include Janssen Pharmaceuticals, Ethicon, DePuy Synthes, McNeil Products Ltd. and Ortho-McNeil Pharmaceuticals.
For the first quarter of 2022, J&J pays a dividend of $1.06 per share. J&J is a dividend aristocrat, raising its dividends for 59 years in a row. The company experienced total sales growth of 5%, to 23.4 billion. Operational growth was 7.7% with an adjusted operational growth of 7.9%. Earnings per share of $1.93 decreased 16.8% and adjusted earnings per share of $2.67 increased 3.1%.
J&J’s consumer health sales increased 1.6% during this period. Pharmaceutical sales grew 9.3% and its MedTech sales grew 8.6%. J&J is a great stock to consider when investing in healthcare.
J&J’s coronavirus vaccine has been associated with a rare but serious blood clotting disorder. On May 6, the FDA imposed new restrictions on who may receive this vaccine. Five months earlier, the CDC decided to give preferential recommendations to the Moderna and Pfizer vaccines. The company announced it will not use the vaccine in its revenue projections.
No. 3 Teladoc Health (NYSE: TEDOC)
During the pandemic, telehealth services boomed. So did Teladoc, one of the oldest telemedicine companies in the business. Founded in 2002 in Dallas, Texas, it is the global leader in virtual care. Its brands include BetterHelp, HealthiestYou, InTouch Health, and MédecinDirect.
In the first quarter of 2022, Teladoc revenue grew 25% year-over-year (YOY), to $564.4 million. However, its net loss totaled $6,674.5 million, or $(41.58) per share. That’s compared to $199.6 million, or $(1.31) per share, in the prior year’s first quarter.
CEO Jason Gorevic warned that there are “dynamics” the company is currently experiencing in the direct-to-consumer mental health and chronic conditions market. In the former, higher advertising costs are generating a lower yield than expected in Teladoc’s marketing spending. In the latter, health plan companies are evaluating long-term strategies.
[gated-content list=’INVESTME’ headline=’Keep Reading This Article and Find Out the Top 2 Healthcare Stocks to Buy Now’ body=’
Enter your email below to read the reveal the top two healthcare stocks.
You’ll also be opted in to receive our free daily e-letter, Investment U, where you’ll find expert investment insight, analysis and stock picks for all the best investment opportunities.
‘ button=’Unlock The Rest’ mvid=’1516177′ coreg=’274702′]
No. 2 UnitedHealth Group (NYSE: UNH)
Based in Minnetonka, Minnesota, UnitedHealth Group is a multinational managed healthcare and insurance company. It’s been dubbed “The Amazon of Healthcare.” So, when investing in healthcare, you’ll want to consider this stock. Subsidiaries include the behemoth Optum, one of the nation’s largest healthcare providers and pharmacy benefit managers. Other subsidiaries include Golden Rule Insurance Company and Oxford Health Plans.
UnitedHealth Group reported first-quarter 2022 revenues of $801 billion, growing 10 billion or 14% YOY. Both United Healthcare and Optum experienced double-digit growth. Earnings from operations were $7 billion, with cash flows from operations at $5.3 billion. In the first quarter of 2022, the operating cost ratio of 14.2% decreased from 14.6% in 2021. That decrease was due to the effects of COVID-19 as well as continued productivity advances. A total of $3.9 billion was returned to shareholders in the first quarter via dividends and share repurchases.
No. 1 Walgreens Boots Alliance (Nasdaq: WBA)
A global retail pharmacy leader, the Walgreen Boots Alliance, Inc. owns the Walgreens retail pharmacy chains in the U.S. and Boots in the U.K. In the U.S., WBA also includes the Duane Reade drugstore chain. The company also has a strong presence in Latin America and Europe.
On March 31, 2022, WBA reported second-quarter 2022 results, including earnings per share of $1.02. That was down from $1.06 compared to the 2021 quarter. Second-quarter sales from continuing operations increased 3 percent over 2021’s second quarter, to $33.8 billion. That was up 3.8% on a constant currency basis. Operating income from continuing operations increased to $1.2 billion, as opposed to $832 million in the second quarter of 2021.
COVID-19 vaccinations and testing help boost U.S. retail sales by 14.7% and Boot UK sales by 22%. In the U.S., retail growth was the highest in 20 years. To date, the company has administered 62.8 million COVID-19 vaccinations. It is the largest pediatric vaccine provider among pharmacies.
In late April 2022, WBA announced a quarterly dividend of $.47.75 cents per share, up 2.1% from the first quarter of 2021.
[/gated-content]
Investing in Healthcare Considerations
When investing in healthcare, look to the long run. Many factors affect stock prices, and the healthcare industry consists of so many sectors. Perform your due diligence on specific areas of the industry by considering demographics, the effects of Medicare or Medicaid funding, potential changes in the regulatory environment, and new trends in medicine. For many investors, mutual funds or ETFs focused on healthcare stocks may prove the best choice.